Worldwide Clinical Trials
69
10
15
38
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
14.5%
10 terminated/withdrawn out of 69 trials
79.2%
-7.3% vs industry average
29%
20 trials in Phase 3/4
50%
19 of 38 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (69)
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
Role: collaborator
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Role: collaborator
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Role: collaborator
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Role: collaborator
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
Role: collaborator
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Role: collaborator
An Open-label Study of XEN1101 in Epilepsy
Role: collaborator
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Role: collaborator
CRF2 Agonist for the Treatment of Worsening Heart Failure
Role: collaborator
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Role: collaborator
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Role: collaborator
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Role: collaborator
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Role: collaborator
Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy
Role: collaborator
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
Role: collaborator
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
Role: collaborator
Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease
Role: collaborator
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Role: collaborator
A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)
Role: collaborator
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
Role: collaborator